by Madaline Spencer | Jul 19, 2024
Thanh Hoang, MD, Program Director for the Endocrine Fellowship at Walter Reed National Military Medical Center, and Mohamed Shakir, MD, U.S. Navy Captain, National Naval Medical Center discuss a study testing romosozumab in an osteogenesis imperfecta patient. ...
by Madaline Spencer | Jul 18, 2024
James Meyer, PharmD, Senior Director of Publications and Medical Communications at Xeris Pharmaceuticals, discusses a post hoc analysis from a phase 3 study testing levoketoconazole in patients with Cushing’s syndrome. Cushing’s syndrome is a rare...
by Madaline Spencer | Jul 17, 2024
Marilyn Tan, MD, Chief of the Endocrine Clinic at Stanford Healthcare, provides an overview of hypoglycemia. Hypoglycemia, or low blood sugar, is most often caused by diabetic medications. However, hypoglycemia commonly goes undiagnosed when there is an...
by Madaline Spencer | Jul 16, 2024
Jairo Noreña, MD, endocrinology fellow at Stanford University, discusses an investigational therapy for the potential treatment of congenital hyperinsulinism. Congenital hyperinsulinism is a rare pediatric genetic disorder characterized by excessive...
by Madaline Spencer | Jul 15, 2024
Evelien Gevers, MD, pediatric endocrinologist at Barts Health and Queen Mary University of London, discusses the delay in diagnosis for Prader-Willi syndrome. Prader-Willi syndrome (PWS) is a rare genetic condition that affects many parts of the body....
